Quarterly report pursuant to Section 13 or 15(d)

Revenue from Contracts with Customers (Tables)

v3.19.1
Revenue from Contracts with Customers (Tables)
3 Months Ended
Mar. 31, 2019
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The Company generates substantially all of its revenue from sales of prescription pharmaceutical products to its customers. The following table presents net revenues disaggregated by type (in thousands):

 
 
Three Months Ended March 31,
 
 
2019
 
2018
Prescribed dietary supplements
 
$
1,791

 
$
2,231

Prescription drugs
 
3,620

 
2,029

Sales force revenue
 

 
223

Total revenue
 
$
5,411

 
$
4,483